These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29057203)

  • 1. Nanotechnological Approaches to Immunosuppression and Tolerance Induction.
    Patel K; Atkinson C; Tran D; Nadig SN
    Curr Transplant Rep; 2017 Jun; 4(2):159-168. PubMed ID: 29057203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro and nanoparticle drug delivery systems for preventing allotransplant rejection.
    Fisher JD; Acharya AP; Little SR
    Clin Immunol; 2015 Sep; 160(1):24-35. PubMed ID: 25937032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-assisted Targeting Delivery Technologies for Preventing Organ Rejection.
    Meng F; Fu Y; Xie H; Wang H
    Transplantation; 2024 Apr; ():. PubMed ID: 38597913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients.
    Geissler EK; Hutchinson JA
    Curr Opin Organ Transplant; 2013 Aug; 18(4):408-15. PubMed ID: 23838645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New directions for induction immunosuppression strategy in solid organ transplantation.
    Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA
    Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression in the era of biological agents.
    Grinyó JM; Cruzado JM; Bestard O; Vidal Castiñeira JR; Torras J
    Adv Exp Med Biol; 2012; 741():60-72. PubMed ID: 22457103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving immunosuppressive regimens for lung transplant recipients.
    Meyer NJ; Bhorade SM
    Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel technologies to engineer graft for tolerance induction.
    Woodward KB; Wang F; Zhao H; Yolcu ES; Shirwan H
    Curr Opin Organ Transplant; 2016 Feb; 21(1):74-80. PubMed ID: 26626421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts and perspectives of immunosuppression in organ transplantation.
    Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
    Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell Therapy in Solid Organ Transplantation.
    Cai S; Chandraker A
    Curr Gene Ther; 2019; 19(2):71-80. PubMed ID: 31161989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive and Contemporary Review on Immunosuppression Therapy for Heart Transplantation.
    Goldraich LA; Leitão SAT; Scolari FL; Marcondes-Braga FG; Bonatto MG; Munyal D; Harrison J; Ribeiro RVP; Azeka E; Piardi D; Costanzo MR; Clausell N
    Curr Pharm Des; 2020; 26(28):3351-3384. PubMed ID: 32493185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.
    Abu-Elmagd KM; Costa G; Bond GJ; Wu T; Murase N; Zeevi A; Simmons R; Soltys K; Sindhi R; Stein W; Demetris A; Mazariegos G
    Transpl Int; 2009 Jan; 22(1):96-109. PubMed ID: 18954362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric heart transplantation: immunosuppression and its complications.
    Russo LM; Webber SA
    Curr Opin Cardiol; 2004 Mar; 19(2):104-9. PubMed ID: 15075734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beginning of clinical tolerance in solid organ allografts.
    Monaco AP
    Exp Clin Transplant; 2004 Jun; 2(1):153-61. PubMed ID: 15859922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression in the pediatric transplant recipient.
    Blondet NM; Healey PJ; Hsu E
    Semin Pediatr Surg; 2017 Aug; 26(4):193-198. PubMed ID: 28964473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant diabetes mellitus. The role of immunosuppression.
    Jindal RM; Sidner RA; Milgrom ML
    Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of small bowel and multivisceral transplantation.
    Vianna RM; Mangus RS; Tector AJ
    Adv Surg; 2008; 42():129-50. PubMed ID: 18953814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression for Lung Transplantation: Current and Future.
    Chandrashekaran S; Crow Pharm SA; Shah SZ; Arendt Pharm CJ; Kennedy CC
    Curr Transplant Rep; 2018 Sep; 5(3):212-219. PubMed ID: 30740294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for minimizing immunosuppression in kidney transplantation.
    Kirk AD; Mannon RB; Swanson SJ; Hale DA
    Transpl Int; 2005 Jan; 18(1):2-14. PubMed ID: 15612977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent immunosuppression after liver transplantation: what is possible?
    Raimondo ML; Burroughs AK
    Drugs; 2002; 62(11):1587-97. PubMed ID: 12109922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.